Physical Health in Schizophrenia and Role of Clinical Pharmacist: A Narrative Review

被引:0
|
作者
Deepak, C. G. [1 ]
Joel, Juno Jerold [1 ]
Bhat, Shrinivasa Undaru [2 ]
机构
[1] NITTE, NGSM Inst Pharmaceut Sci, Dept Pharm Practice, Mangalore 575018, Karnataka, India
[2] NITTE, KS Hegde Med Acad, Dept Psychiat, Mangaluru, Karnataka, India
关键词
Schizophrenia; Physical illness; Cardiovascular diseases; Metabolic diseases; Clinical pharmacist; MANAGEMENT;
D O I
10.5530/jyp.2024.16.78
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Schizophrenia is a complex psychiatric disease with an unknown aetiology affecting the biological functions of the brain. It is a psychiatric condition affecting both genders irrespective of race, social class and residential status. Globally lifetime of disease is 0.4%, with a 2.5% mortality rate. Schizophrenic patients die at a young age, about 15-20 years earlier than the general population. Premature death in schizophrenic patients is mainly due to physical illness in the form of cardiovascular and metabolic diseases. Seventy-five percent of patients with a diagnosis of schizophrenia exhibit a minimum of one physical illness and it is more complicated if symptoms are severe. Long-term drug therapy is an eminent risk factor for developing physical illnesses. There is no known cure for schizophrenia; thus, it requires lifelong treatment with antipsychotics. Second-Generation Antipsychotics (SGAs), except clozapine are the first-line drugs for treating schizophrenia. These agents are likely to develop cardiovascular and metabolic side effects like hypertension, hyperlipidemia, weight gain, diabetes mellitus and obesity. Another contributing factor is a sedentary lifestyle. Ignoring these factors while undergoing treatment may result in increased burden, decreased quality of life and shorter life expectancy. Clinical pharmacists have a vital role in managing these patients through proper counselling and medication monitoring for better control of the illness.
引用
收藏
页码:607 / 612
页数:6
相关论文
共 50 条
  • [31] Toxic role in schizophrenia: A review by a clinical case
    Canseco Navarro, M.
    Pena Serrano, A.
    Hernandez Sanchez, J. M.
    Canccino Botello, M.
    Molina Lopez, F.
    Machado Vera, M.
    EUROPEAN PSYCHIATRY, 2016, 33 : S292 - S292
  • [32] A lifetime of mental health treatments for people with schizophrenia: update and narrative review
    DeLisi, Lynn E.
    CURRENT OPINION IN PSYCHIATRY, 2024, 37 (03) : 140 - 146
  • [33] Physical Literacy, Physical Activity, and Health: A Citation Content Analysis and Narrative Review
    Kathryn Fortnum
    Meyene Duque Weber
    Dean Dudley
    Eloisa Tudella
    Matthew Kwan
    Veronique Richard
    John Cairney
    Sports Medicine - Open, 11 (1)
  • [34] Risperidone ISM as a New Option in the Clinical Management of Schizophrenia: A Narrative Review
    Alamo, Cecilio
    ADVANCES IN THERAPY, 2022, 39 (11) : 4875 - 4891
  • [35] Neurostructural, Neurofunctional, and Clinical Features of Chronic, Untreated Schizophrenia: A Narrative Review
    Tang, Biqiu
    Yao, Li
    Strawn, Jeffrey R.
    Zhang, Wenjing
    Lui, Su
    SCHIZOPHRENIA BULLETIN, 2024,
  • [36] Risperidone ISM as a New Option in the Clinical Management of Schizophrenia: A Narrative Review
    Cecilio Álamo
    Advances in Therapy, 2022, 39 : 4875 - 4891
  • [37] Connecting adolescent friendships to physical health outcomes: A narrative review
    Ehrhardt, Alexandra D.
    Schacter, Hannah L.
    SOCIAL DEVELOPMENT, 2024, 33 (02)
  • [38] COMMON MENTAL AND PHYSICAL HEALTH ISSUES WITH ELDERLY: A NARRATIVE REVIEW
    Sharma, Guddo
    Morishetty, Sandeep Kumar
    ASEAN JOURNAL OF PSYCHIATRY, 2022, 23
  • [39] Examining the Role of Physical Activity Interventions in Modulating Androgens and Cardiovascular Health in Postmenopausal Women: A Narrative Review
    Elliott, Cara G.
    Vidal-Almela, Sol
    Harvey, Paula
    O'Donnell, Emma
    Scheid, Jennifer L.
    Visintini, Sarah
    Reed, Jennifer L.
    CJC OPEN, 2023, 5 (01) : 54 - 71
  • [40] The role of carotenoids in bone health-A narrative review
    Kulczynski, Bartosz
    Sidor, Andrzej
    Brzozowska, Anna
    Gramza-Michaowska, Anna
    NUTRITION, 2024, 119